Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06070454

Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
91 (estimated)
Sponsor
University of Virginia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary: * To measure the rate of perioperative vulvovaginitis in a population of patients in central VA with non-malignant vulvar disease who require surgical excision * To correlate the rate of vulvovaginitis with rate of wound cellulitis and incisional breakdown in patients undergoing SPV/WLE for vulvar disease We will use a vulvovaginal swab to test for the most common causes of vulvovaginitis - bacterial vaginosis (BV), trichomonas, and candida. The swab will be collected preoperatively on day of surgery. The outcome will be evaluated by phone call to patient at 1 week after surgery and physical exam at the postoperative visit between 4-6 weeks.

Detailed description

Primary: * To measure the rate of perioperative vulvovaginitis in a population of patients in central VA with non-malignant vulvar disease who require surgical excision * To correlate the rate of vulvovaginitis with rate of wound cellulitis and incisional breakdown in patients undergoing SPV/WLE for vulvar disease We will use a vulvovaginal swab to test for the most common causes of vulvovaginitis - bacterial vaginosis (BV), trichomonas, and candida. The swab will be collected preoperatively on day of surgery. The outcome will be evaluated by phone call to patient at 1 week after surgery and physical exam at the postoperative visit between 4-6 weeks.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTVaginitis panelvulvovaginal swab to test for the most common causes of vulvovaginitis - bacterial vaginosis (BV), trichomonas, and candida

Timeline

Start date
2024-04-25
Primary completion
2026-06-01
Completion
2026-08-01
First posted
2023-10-06
Last updated
2025-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06070454. Inclusion in this directory is not an endorsement.